Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
RIG-I activation inhibits ebolavirus replication
Christina F. Spiropoulou
, Priya Ranjan
, Melissa B. Pearce
, Tara K. Sealy
, César G. Albariño
, Shivaprakash Gangappa
, Takashi Fujita
, Pierre E. Rollin
, Stuart T. Nichol
,
Thomas G. Ksiazek
, Suryaprakash Sambhara
Research output
:
Contribution to journal
›
Article
›
peer-review
43
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'RIG-I activation inhibits ebolavirus replication'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ebola Virus
100%
RIG-I-like Receptors
100%
Virus
66%
Fatality
66%
Retinoic Acid-inducible Gene I (RIG-I)
66%
Public Health
33%
Infectivity
33%
Hemorrhagic Fever Virus
33%
Severe Disease
33%
Aerosol
33%
Diverse Groups
33%
Filovirus
33%
Ebola Hemorrhagic Fever
33%
Marburg Virus
33%
Evolutionarily Conserved
33%
Viral nucleic Acid
33%
Biothreat
33%
Antiviral Development
33%
Nucleic Acid Sensors
33%
Medicine and Dentistry
Ebolavirus
100%
Case Fatality Rate
66%
Antiviral Drug
66%
Virus
66%
Public Health
33%
Infection
33%
Antivirus Agent
33%
Filovirus
33%
Immunosuppressive Drug
33%
Nucleic Acid
33%
Viral Hemorrhagic Fever
33%
Marburgvirus
33%
Ebola Hemorrhagic Fever
33%
Diseases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Ebola Virus
100%
Antiviral Drug
66%
Case Fatality Rate
66%
Infection
33%
Antivirus Agent
33%
Virus Hemorrhagic Fever
33%
Nucleic Acid
33%
Marburg Virus
33%
Filovirus
33%
Immunosuppressive Agent
33%
Ebola Hemorrhagic Fever
33%
Diseases
33%